↓
 

ParagraphFour.com

Pharmaceutical Patent Database

ParagraphFour.com
  • Home
  • About
  • Paragraph IV Explained
  • FAQ & Terms
  • The PIV Blog
  • PIV Data
    • Get Access
Home→Non-PIV Patent Cases and Non-PIV Inter Partes Reviews

Non-PIV Patent Cases and Non-PIV Inter Partes Reviews

Home › Forums › Non-PIV Patent Cases and Non-PIV Inter Partes Reviews

This forum contains 1 topic, and was last updated by  brick 15 years, 10 months ago.

Viewing topic 1 (of 1 total)
    • Topic
    • Voices
    • Posts
    • Freshness
    • The Non-PIV Cases and IPR’s

      Started by:  brick

    • 1
    • 1
    • 15 years, 10 months ago

       brick

  •  

Viewing topic 1 (of 1 total)

You must be logged in to create new topics.

Latest updates

Rhofade®(oxymetazoline) Topical Cream
Annual Sales
Company ACLARIS
Date of First Filing June 20, 2019

Paragraph IV Applicant: Taro
Case Name: ACLARIS THERAPEUTICS INC et al v. TARO PHARMACEUTICALS INC
Court/Case #: Delaware District Court (dedc) 1:2019cv01910
Date Filed: 10/8/19
Judge:
Product Strength: 1%
Litigated Patents…[Read more]

Profile picture of parryashford 2 days, 21 hours ago

Cleviprex®(clevidipine) Injectable Emulsion
Annual Sales
Company CHIESI
Date of First Filing July 2, 2019

Paragraph IV Applicant: Aurobindo
Case Name: CHIESI USA INC et al v. AUROBINDO PHARMA USA INC et al
Court/Case #: New Jersey District Court (njdc) 3:2019cv18756
Date Filed: 10/7/19
Judge: Wolfson
Product Strength: 25mg/50mL…[Read more]

Profile picture of parryashford 6 days, 13 hours ago

Kengreal®(cangrelor) For Injection
Annual Sales
Company CHIESI
Date of First Filing June 24, 2019

Paragraph IV Applicant: MSN Labs
Case Name: CHIESI USA INC et al v. MSN PHARMACEUTICALS INC et al
Court/Case #: New Jersey District Court (njdc) 2:2019cv18654
Date Filed: 9/30/19
Judge: Arleo
Product Strength: 50mg/vial
Litigated…[Read more]

Profile picture of parryashford 1 week, 6 days ago
The Paragraph Four Report®, ParagraphFour.com® and the PFOUR logo are registered trademarks of Parry Ashford Inc. • ©Parry Ashford Inc. 2019
↑